Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

14 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/14/3166033/0/en/BioXcel-Therapeutics-Announces-Positive-Results-from-Correlation-Study-Supporting-SERENITY-At-Home-Exploratory-Efficacy-Outcomes.html

13 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/13/3165413/0/en/BioXcel-Therapeutics-to-Ring-Nasdaq-Closing-Bell-on-October-14-to-Celebrate-a-Transformative-Milestone-in-Neuroscience-Innovation.html

18 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/18/3152274/0/en/BioXcel-Therapeutics-Regains-Compliance-with-Nasdaq-Market-Value-of-Listed-Securities-Requirements.html

10 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/10/3147596/0/en/BioXcel-Therapeutics-Reports-Positive-Topline-Exploratory-Efficacy-Data-from-SERENITY-At-Home-Pivotal-Phase-3-Safety-Trial-for-Agitation-Associated-with-Bipolar-Disorders-or-Schizo.html

04 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/04/3144339/0/en/BioXcel-Therapeutics-to-Present-at-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html

26 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/26/3139590/0/en/BioXcel-Therapeutics-To-Announce-Topline-Results-from-SERENITY-At-Home-Pivotal-Phase-3-Safety-Trial-for-Acute-Treatment-of-Agitation-Associated-with-Bipolar-Disorders-or-Schizophre.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE